Exciting News from the J.P. Morgan Healthcare Conference 2024
ArtiDock to launch on NVIDIA’s BioNeMo platform
Exciting News from the J.P. Morgan Healthcare Conference 2024
ArtiDock to launch on NVIDIA’s BioNeMo platform
PARTNERSHIP
Announcement
Summary
At this year’s J.P. Morgan Healthcare Conference, Receptor.AI’s ArtiDock was featured by NVIDIA’s VP of Healthcare alongside innovations from Google DeepMind and MIT for its contribution to drug discovery. ArtiDock will soon be available on NVIDIA’s BioNeMo platform, expanding its accessibility for scientific use. Additionally, Receptor.AI has developed an optimized version, ArtiDock v1.5, which demonstrated improved performance on PoseBusters v3 and will be detailed further in upcoming materials.
Full Text
This year's J.P. Morgan Healthcare Conference featured a wide range of developments in healthcare and AI. Among them was a presentation by Kimberly Powell, NVIDIA's VP of Healthcare, which included a mention of Receptor.AI’s ArtiDock model.
Our AI model for binding pose prediction, ArtiDock, was presented alongside work from Google DeepMind and the Massachusetts Institute of Technology as an example of progress in AI-enabled drug discovery.
ArtiDock will soon be available on NVIDIA's BioNeMo platform, broadening its accessibility and application within the scientific and biotech communities.
In parallel, we have developed an optimized version — ArtiDock v1.5 — which has undergone benchmarking on PoseBusters v3 and demonstrated improved performance. These results reflect ongoing efforts to enhance predictive accuracy and computational efficiency.
We are currently preparing more detailed materials on these developments and will share them later this month.
NVIDIA Presentation at J.P. Morgan Healthcare Conference 2024
